Skip to content

Investigating the Effect of Ultrasound Therapy on Vitamin D level and Symptoms in Patients with sinusitis

Investigating the Effect of Ultrasound Therapy on Vitamin D level and Symptoms in Patients with Chronic Rhinosinusitis

Status
Recruiting
Phases
Phase 2
Study type
Interventional
Source
IRCT
Registry ID
IRCT20251225068441N1
Enrollment
20
Registered
2026-05-11
Start date
2026-05-22
Completion date
Unknown
Last updated
2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic rhinosinusitis without nasal polyps. Chronic sinusitis

Interventions

Intervention group: The treatment protocol is based on a similar study by Ansari et al. in 2012. Ultrasound therapy will be performed by a physiotherapist using the same device, 3 days a week, for 10

Sponsors

Tehran University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Individuals aged 18 to 65 Diagnosis of chronic rhinosinusitis by an otolaryngologist according to criteria published by the Rhinosinusitis Group and approved by the American Academy of Otolaryngology Positive CT scan result People with vitamin D levels less than 30 ng/ml

Exclusion criteria

Exclusion criteria: Active malignancy in the head/neck area Active infection or abscess in the frontal and maxillary sinuses Recent facial injury or fracture in the maxillary sinus and frontal area within the past six months Having electronic devices implanted near the head and neck area Previous surgery on the frontal and maxillary sinuses Taking vitamin D supplements in the past six months Use of corticosteroids and immunosuppressive drugs in the past six months Extreme obesity or anatomical variants that prevent proper ultrasound application in that area

Design outcomes

Primary

MeasureTime frame
Serum vitamin D level (25(OH)D). Timepoint: At the beginning of the study (before the intervention) and 24 hours after the last treatment session. Method of measurement: To measure serum vitamin D levels, the ECLIA method will be used to measure blood levels.;Severity of clinical symptoms. Timepoint: At the beginning of the study (before the intervention) and the tenth session. Method of measurement: Sinonasal Outcome Test-22 Questionnaire.

Secondary

MeasureTime frame
C reactive protein. Timepoint: At the beginning of the study (before the intervention) and 24 hours after the tenth session. Method of measurement: Blood test.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactBita Azmayesh Saravani

Tehran University of Medical Sciences

bita.az.s8083@gmail.com+98 21 2121 2121

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Jun 11, 2026